TB or not TB: a disease forgotten, but not gone.
TB or not TB: a disease forgotten, but not gone.
复制标题
结核病或非结核病:一种被遗忘的疾病,但并未消失。
DOI:
10.1111/j.1865-1682.2009.01084.x
复制
发表时间:
2009
影响因子:
4.3
通讯作者:
Coffey TJ
中科院分区:
文献类型:
--
作者:
Coffey TJ
As a health problem, tuberculosis (TB) does not attract the same high profile of human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS). Human TB, caused primarily by Mycobacterium tuberculosis, usually manifests in the lungs (pulmonary), but can also affect other parts of the body (extra-pulmonary). With 9 million new cases of TB and nearly 2 million deaths from TB around the world every year, it is the leading cause of death among curable infectious diseases. Co-infection with HIV and the emergence of multidrug resistant strains has contributed to TB remaining a global challenge. While the Directly Observed Treatment Short course (DOTS), a highly effective low cost technology treatment recommended by the World Health Organization (WHO), has helped to cure about 20 million patients, incidence of the disease has tripled since 1990 in 21 African countries with high levels of HIV. Tuberculosis cases are increasing at rates of between 3% and 4% per annum in Africa, putting further pressure on chronically poor and inadequate health facilities. What needs to be done to combat the rising epidemic of TB? Health experts have listed a number of measures they believe will go a long way towards tackling this increasingly deadly disease. These include improving diagnostic testing, developing new vaccines, drugs and treatment regimes, conducting social research to reduce the risk of the disease, addressing the issue of poverty and examining more critically the spread of TB and HIV co-infection and multidrug resistant TB. Clearly all the above, although they are by no means exhaustive, are crucial for meeting the big global health challenges posed by a resurgent TB, particularly in Africa. However, many of these measures are not exclusive for human TB, but can directly be transferred to bovine TB as well. The situation in Africa is exacerbated by the fact that human TB may not necessarily be caused by Mycobacterium tuberculosis alone. Its bovine counterpart, M. bovis, may represent an unrecognized cause of morbidity and mortality. Although most cases are caused by M. tuberculosis, reliable information is not generally available on the incidence of human disease caused by M. bovis, especially in developing countries, where diagnosis is based on microscopic examination and techniques for differentiating the two organisms are not widely accessible. Mycobacterium bovis infection in humans was important in the late 19th and early 20th centuries, and accounted for a substantial portion of human TB in Europe. With the implementation of better housing for cattle and humans, pasteurization and the development of eradication programmes in cattle, reports of human M. bovis infection decreased. M. bovis is now estimated to account for< 1% of human TB in most industrialized countries, but is thought be more prevalent in particular areas and populations. Recently, outbreaks of M. bovis in wild animals, which act as a reservoir for the disease, have frustrated the eradication of M. bovis from cattle. Whereas in the UK, badgers may play an important role as a reservoir for infection, other animals, such as cervids (deer) and possums may act as reservoirs in other nations, resulting in the slaughter, quarantine and depopulation of cattle herds infected with M. bovis, loss of valuable blood lines, and limitations on the international export of valuable breeding animals and semen. The importance of M. bovis infections in wild animal populations in many countries has been documented, but in many developing countries no definitive information is available about the scale of M. bovis infection in domestic or wild species. Pasteurization is often …